Frontida Biopharm Revenue and Competitors

Location

$8.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Frontida Biopharm's estimated annual revenue is currently $7.2M per year.(i)
  • Frontida Biopharm's estimated revenue per employee is $100,500
  • Frontida Biopharm's total funding is $8.4M.

Employee Data

  • Frontida Biopharm has 72 Employees.(i)
  • Frontida Biopharm grew their employee count by -5% last year.

Frontida Biopharm's People

NameTitleEmail/Phone
1
Director, Research & Development Technical Sevices and ValidationReveal Email/Phone
2
Director Manufacturing OperationsReveal Email/Phone
3
Associate Director, ARDReveal Email/Phone
4
Director, Human ResourcesReveal Email/Phone
5
Procurement ManagerReveal Email/Phone
6
Project ManagerReveal Email/Phone
7
Quality Assurance ManagerReveal Email/Phone
8
Sr. ProgrammerReveal Email/Phone
9
Team Leader in Analytical Research and Development DeptReveal Email/Phone
10
QA Label Control llReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M40230%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Frontida Biopharm?

Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.

keywords:N/A

$8.4M

Total Funding

72

Number of Employees

$7.2M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Frontida Biopharm News

2022-04-06 - Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion EIN News

Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion EIN News

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.2M72-15%N/A
#2
$17.5M723%N/A
#3
$15M7211%N/A
#4
$18.8M7218%N/A
#5
$9.7M727%N/A